Oncogene - Table of Contents alert Volume 31 Issue 6

TABLE OF CONTENTS Volume 31, Issue 6 (February 2012) In this issue Original Articles Short Communication Also new AOP Advertisement Celebrating 50 Years Rockland, a leader in the production of the highest quality antibodies and assays, marks 50 years of providing reagents for Cancer, Cell Biology, Cell Signaling and Neuroscience research. Manufactured near Philadelphia, PA, Rockland products are guaranteed to give predictable, repeatable results. Protect your experiments with Rockland antibodies. Compromise elsewhere. Visit our content-rich website at www.rockland-inc.com Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Please take a look at this article that recently published in The Journal of Investigative Dermatology! RASSF10 Promoter Hypermethylation Is Frequent in Malignant Melanoma of the Skin but Uncommon in Nevus Cell Nevi FREE Peter Helmbold et al. | doi:10.1038/jid.2011.380   Original Articles Top Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype J Jiang, Y Zhang, S Chuai, Z Wang, D Zheng, F Xu, Y Zhang, C Li, Y Liang and Z Chen Oncogene 2012 31: 671-682; advance online publication, July 11, 2011; 10.1038/onc.2011.282 Abstract | Full Text Death-associated protein kinase increases glycolytic rate through binding and activation of pyruvate kinase I Mor, R Carlessi, T Ast, E Feinstein and A Kimchi Oncogene 2012 31: 683-693; advance online publication, July 4, 2011; 10.1038/onc.2011.264 Abstract | Full Text Sex differences in the GSK3β-mediated survival of adherent leukemic progenitors J Bertrand, M Despeaux, S Joly, E Bourogaa, N Gallay, C Demur, P Bonnevialle, F Louache, V Maguer-Satta, N Vergnolle, B Payrastre and C Racaud-Sultan Oncogene 2012 31: 694-705; advance online publication, July 4, 2011; 10.1038/onc.2011.258 Abstract | Full Text Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis T Smirnova, Z N Zhou, R J Flinn, J Wyckoff, P J Boimel, M Pozzuto, S J Coniglio, J M Backer, A R Bresnick, J S Condeelis, N E Hynes and J E Segall Oncogene 2012 31: 706-715; advance online publication, July 4, 2011; 10.1038/onc.2011.275 Abstract | Full Text A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer S Rao, L S Lyons, C D Fahrenholtz, F Wu, A Farooq, W Balkan and K L Burnstein Oncogene 2012 31: 716-727; advance online publication, July 18, 2011; 10.1038/onc.2011.273 Abstract | Full Text Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinoma E W L Law, A K L Cheung, V I Kashuba, T V Pavlova, E R Zabarovsky, H L Lung, Y Cheng, D Chua, D Lai-wan Kwong, S W Tsao, T Sasaki, E J Stanbridge and M L Lung Oncogene 2012 31: 728-738; advance online publication, July 11, 2011; 10.1038/onc.2011.272 Abstract | Full Text Regulated ATF5 loss-of-function in adult mice blocks formation and causes regression/eradication of gliomas A Arias, M W Lamé, L Santarelli, R Hen, L A Greene and J M Angelastro Oncogene 2012 31: 739-751; advance online publication, July 4, 2011; 10.1038/onc.2011.276 Abstract | Full Text MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63 L D Gamble, U R Kees, D A Tweddle and J Lunec Oncogene 2012 31: 752-763; advance online publication, July 4, 2011; 10.1038/onc.2011.270 Abstract | Full Text Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2 A Chao, C-Y Lin, Y-S Lee, C-L Tsai, P-C Wei, S Hsueh, T-I Wu, C-N Tsai, C-J Wang, A-S Chao, T-H Wang and C-H Lai Oncogene 2012 31: 764-775; advance online publication, July 4, 2011; 10.1038/onc.2011.269 Abstract | Full Text The von Hippel–Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C X Niu, T Zhang, L Liao, L Zhou, D J Lindner, M Zhou, B Rini, Q Yan and H Yang Oncogene 2012 31: 776-786; advance online publication, July 4, 2011; 10.1038/onc.2011.266 Abstract | Full Text Neutralization of the γ-secretase activity by monoclonal antibody against extracellular domain of nicastrin I Hayashi, S Takatori, Y Urano, Y Miyake, J Takagi, M Sakata-Yanagimoto, H Iwanari, S Osawa, Y Morohashi, T Li, P C Wong, S Chiba, T Kodama, T Hamakubo, T Tomita and T Iwatsubo Oncogene 2012 31: 787-798; advance online publication, July 4, 2011; 10.1038/onc.2011.265 Abstract | Full Text Short Communication Top Functional differences among BRCA1 missense mutations in the control of centrosome duplication Z Kais, N Chiba, C Ishioka and J D Parvin Oncogene 2012 31: 799-804; advance online publication, July 4, 2011; 10.1038/onc.2011.271 Abstract | Full Text Advertisement Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.